Youtao Xu

2.7k total citations
43 papers, 2.0k citations indexed

About

Youtao Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Youtao Xu has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 24 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Youtao Xu's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (14 papers) and MicroRNA in disease regulation (6 papers). Youtao Xu is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (14 papers) and MicroRNA in disease regulation (6 papers). Youtao Xu collaborates with scholars based in China and United States. Youtao Xu's co-authors include Lin Xu, Rong Yin, Mantang Qiu, Gaochao Dong, Wenjia Xia, Siwei Wang, Jingwen Hu, Jie Wang, Jie Wang and Qixing Mao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Youtao Xu

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youtao Xu China 21 1.6k 1.4k 294 249 102 43 2.0k
Qiong Shao China 17 1.3k 0.8× 1.1k 0.8× 219 0.7× 446 1.8× 110 1.1× 41 1.8k
Mu Xu China 21 2.1k 1.4× 2.0k 1.4× 191 0.6× 235 0.9× 80 0.8× 39 2.5k
Junmin Song China 16 1.3k 0.9× 1.1k 0.8× 161 0.5× 191 0.8× 115 1.1× 40 1.7k
Yuki Takano Japan 18 1.3k 0.8× 1.1k 0.8× 142 0.5× 257 1.0× 125 1.2× 52 1.6k
Guoliang Ye China 24 1.7k 1.1× 1.6k 1.1× 255 0.9× 188 0.8× 265 2.6× 58 2.2k
Guixi Zheng China 24 1.2k 0.8× 1.2k 0.8× 168 0.6× 254 1.0× 188 1.8× 55 1.7k
Genta Sawada Japan 18 1.3k 0.8× 1.1k 0.8× 172 0.6× 321 1.3× 165 1.6× 37 1.7k
Tong Lu China 19 716 0.5× 523 0.4× 259 0.9× 181 0.7× 113 1.1× 67 1.1k
Junfen Xu China 20 1.1k 0.7× 982 0.7× 214 0.7× 313 1.3× 71 0.7× 54 1.6k

Countries citing papers authored by Youtao Xu

Since Specialization
Citations

This map shows the geographic impact of Youtao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youtao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youtao Xu more than expected).

Fields of papers citing papers by Youtao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youtao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youtao Xu. The network helps show where Youtao Xu may publish in the future.

Co-authorship network of co-authors of Youtao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Youtao Xu. A scholar is included among the top collaborators of Youtao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youtao Xu. Youtao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
He, Huan, Youtao Xu, Xinru Chen, et al.. (2025). Carboxymethyl chitosan oligosaccharide prevents the progression of chronic kidney disease as a Nrf2-dependent apoptosis inhibitor. Carbohydrate Polymer Technologies and Applications. 9. 100728–100728. 1 indexed citations
3.
Xu, Youtao, et al.. (2025). ADH1B regulates tumor stemness by activating the cAMP/PKA/CREB1 signaling axis to inhibit recurrence and metastasis of lung adenocarcinoma. Biochemical and Biophysical Research Communications. 760. 151681–151681.
4.
Ma, Zhifei, Hao Chen, Zhijun Xia, et al.. (2023). Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing. Journal of Experimental & Clinical Cancer Research. 42(1). 169–169. 11 indexed citations
5.
Xie, Xiaodong, et al.. (2023). Value of dual-layer spectral detector CT in predicting lymph node metastasis of non-small cell lung cancer. Quantitative Imaging in Medicine and Surgery. 14(1). 749–764. 2 indexed citations
6.
Chen, Peng, et al.. (2023). Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche. Cancer Letters. 566. 216234–216234. 43 indexed citations
7.
Wang, Meiqin, Youtao Xu, Qing Chen, et al.. (2023). Value of spectral computed tomography-derived quantitative parameters based on full volume analysis in the diagnosis of benign/malignant and pathological subtypes of solitary pulmonary nodules. Quantitative Imaging in Medicine and Surgery. 13(6). 3827–3840. 3 indexed citations
8.
Zhang, Yi, et al.. (2022). Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer. Annals of Diagnostic Pathology. 61. 152045–152045. 3 indexed citations
9.
Wang, Siwei, Chencheng Han, Tongyan Liu, et al.. (2021). FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma. SHILAP Revista de lepidopterología. 11(2). e316–e316. 11 indexed citations
10.
Zhang, Yi, Lei Xia, Dawei Ma, et al.. (2021). 90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary. Frontiers in Oncology. 11. 722808–722808. 5 indexed citations
11.
12.
Liu, Tongyan, Panqi Fang, Chencheng Han, et al.. (2019). Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer. Journal of Cellular and Molecular Medicine. 24(1). 711–721. 15 indexed citations
13.
Qiu, Mantang, Wenjia Xia, Rui Chen, et al.. (2018). The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma. Cancer Research. 78(11). 2839–2851. 215 indexed citations
14.
Wang, Siwei, Chunxiao Sun, Jianhua Li, et al.. (2017). Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers. Cancer Letters. 408. 112–120. 190 indexed citations
15.
Xia, Wenjia, Mantang Qiu, Rui Chen, et al.. (2016). Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Scientific Reports. 6(1). 35576–35576. 229 indexed citations
16.
Li, Zhongyou, et al.. (2015). Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study. World Journal of Surgical Oncology. 13(1). 128–128. 20 indexed citations
17.
Li, Ming, Mantang Qiu, Youtao Xu, et al.. (2015). Differentially expressed protein-coding genes and long noncoding RNA in early-stage lung cancer. Tumor Biology. 36(12). 9969–9978. 26 indexed citations
18.
Xia, Wenjie, Youtao Xu, Qixing Mao, et al.. (2015). Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies. Medical Oncology. 32(2). 442–442. 19 indexed citations
19.
Qiu, Mantang, Jie Wang, Youtao Xu, et al.. (2014). Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 24(1). 206–212. 156 indexed citations
20.
Qiu, Mantang, Youtao Xu, Xin Yang, et al.. (2014). CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biology. 35(6). 5375–5380. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiong Shao Breakdown of academic impact, for papers by Mu Xu Breakdown of academic impact, for papers by Junmin Song Breakdown of academic impact, for papers by Yuki Takano Breakdown of academic impact, for papers by Guoliang Ye Breakdown of academic impact, for papers by Guixi Zheng Breakdown of academic impact, for papers by Genta Sawada Breakdown of academic impact, for papers by Tong Lu Breakdown of academic impact, for papers by Junfen Xu
Rankless by CCL
2026